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Abstract
Background: The centromere plays a crucial role in ensuring the fidelity of chromosome segregation during cell
divisions. However, in cancer and constitutional disorders, the presence of more than one active centromere on
a chromosome may be a contributing factor to chromosome instability and could also have predictive value in
disease progression, making the detection of properly functioning centromeres important. Thus far, antibodies that
are widely used for functional centromere detection mainly work on freshly harvested cells whereas most cytogenetic
samples are stored long-term in methanol-acetic acid fixative. Hence, we aimed to identify antibodies that would
recognise active centromere antigens on methanol-acetic acid fixed cells.
Results: A panel of active centromere protein antibodies was tested and we found that a rabbit monoclonal antibody
against human CENP-C recognises the active centromeres of cells fixed in methanol-acetic acid. We then tested and
compared combinations of established methods namely centromere fluorescence in situ hybridisation (cenFISH),
centromere protein immunofluorescence (CENP-IF) and multicolour FISH (mFISH), and showed the usefulness of CENP-IF
together with cenFISH followed by mFISH (CENP-IF-cenFISH-mFISH) with the aforementioned anti-CENP-C antibody.
We further demonstrated the utility of our method in two cancer cell lines with high proportion of centromere defects
namely neocentromere and functional dicentric.
Conclusions: We propose the incorporation of the CENP-IF-cenFISH-mFISH method using a commercially available rabbit
monoclonal anti-CENP-C into established methods such as dicentric chromosome assay (DCA), prenatal karyotype
screening in addition to constitutional and cancer karyotyping. This method will provide a more accurate assessment of
centromere abnormality status in chromosome instability disorders.
Keywords: Centromere, CENP-A, CENP-C, Immunofluorescence, Fluorescence in situ hybridisation (FISH), Multicolour FISH
(mFISH), Neocentromere, Dicentric, Dicentric chromosome assay (DCA), Human erythroleukaemia (HEL) cell line
Background
One of the hallmarks of cancer is genome instability, often
characterised by the presence of aneuploidy and genetic
heterogeneity resulting from chromosome missegregation
or defective DNA repair followed by the failure to enter
cellular arrest or death [1, 2]. Such genetic heterogeneity
ranges from the extent seen in leukaemias, generally
presented with simple chromosomal rearrangements, to
carcinomas that are often complex [3, 4]. It is only with
cumulative method improvements and technological
advancements made over the past 60 years that we are
able to better understand disease mechanisms, and
then apply the knowledge to cancer diagnosis, classifi-
cation, prognosis, treatment selection and monitoring
after treatment using the combination of molecular
pathology, molecular cytogenetics and genomics in
cancer research [5, 6].
One such technical advancement is the combination
of RNA or DNA fluorescence in situ hybridisation
(FISH) with immunofluorescence, commonly used for
detection of RNA or DNA together with the protein of
interest in or on the same cell. Co-detection of both
genetic and the protein (epigenetic) components is espe-
cially crucial in determining the activity status of a
centromere — whether it is functional (active) or non-
functional (inactive). The human centromere is a DNA-
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protein structure consisting of the repetitive α-satellite
DNA wrapping around nucleosomes containing CENP-
A that specify the inner kinetochore onto which other
kinetochore protein complexes assemble [7]. A properly
functioning centromere is essential for correct chromo-
some segregation during cell divisions.
For cytogenetic investigations in the research setting,
combinations of FISH and multicolour FISH (mFISH)
performed on fixed cells as well as immunofluorescence
followed by FISH (Imm-FISH) performed on freshly
harvested cells are routinely used. However, for the stud-
ies of the centromere regions, most antibodies raised
against human centromere proteins do not recognise the
epitopes of their targets after fixation in methanol-acetic
acid despite using the method proposed by Earnshaw et
al. [8]. This includes immersing cell preparations into a
low ionic strength buffer to unravel the conformation of
the compact chromosome to improve accessibility of
target antigen and then returning the cells to buffer at
physiological ionic strength to restore the chromosome
morphology [8]. As for the current Imm-FISH carried
out on freshly harvested cells, the morphology of the
chromosomes is often distorted due to the involvement
of the cytocentrifugation step [9, 10].
In this paper, we report on and discuss (1) the screen-
ing outcome of several kinetochore antibodies for fixed
cells, (2) the difference between the proposed method
involving immunocytochemistry, FISH and mFISH, and
the combination of other methods, and (3) the potential
utility of the proposed method with the positive anti-
body, rabbit monoclonal anti-CENP-C, in identifying
chromosomes with structural centromere defects in
clinical samples of patients with congenital diseases or
cancer as exemplified using T-47D, a breast cancer cell
line, and SN12C, a renal cancer cell line, from the NCI-
60 cancer panel.
For the comparison of methods aforementioned, the
human erythroleukaemia (HEL) cell line was used be-
cause MacKinnon et al. [11] have shown by FISH that
HEL has two large, rearranged chromosomes positive for
multiple nucleolar organiser regions and three rear-
ranged chromosomes that contain centromere DNA se-
quences from two different chromosomes. HEL has been
widely used for cell biology and differentiation studies in
addition to the extensive data generated from a variety
of techniques namely whole chromosome painting,
single nucleotide polymorphism (SNP) array, OncoMap
sequencing, mFISH, multicolour chromosome banding
(M-BAND) and targeted FISH [11].
Autoimmune antibodies in the sera of scleroderma
patients were known to react to intranuclear antigens of
tissue sections but a subset were pinpointed to stain the
centromere region after substantiation with mitotic cells
by Moroi et al. [12]. In 1985, the anti-centromere
antibodies (ACAs) from the sera of CREST (calcinosis,
Raynaud’s phenomenon, esophageal dismotility, sclero-
dactyly, telangiectasia) variant of scleroderma patients
led to the discovery of the first three centromere pro-
teins namely CENP-A (17 kDa), CENP-B (80 kDa) and
CENP-C (140 kDa), named from the lowest molecular
weight to the highest [13].
Some ACAs had been shown to work on methanol-
acetic acid fixed cells. However, they usually recognise
multiple centromere proteins depending on the individ-
ual serum and are limited in supply since they are re-
stricted to individual autoimmune patients. Hence,
ACAs are limited in their use for functional centromere
identification where CENP-A and CENP-C are found ex-
clusively on active centromeres but CENP-B is localised
to the 17-bp CENP-B box of the centromeric repetitive
DNA sequence regardless of its activity status [10, 14].
CENP-A and CENP-C are both part of the constitutive
centromere-associated network (CCAN) that forms the
inner kinetochore plate onto which other protein
complexes assemble. CENP-A is a histone-H3 variant
constituting the nucleosome core in a portion of the
centromeric chromatin [15]. For CENP-A related stud-
ies, a mouse monoclonal antibody against human
CENP-A (Clone: 3–19) generated by Ando et al. [16] has
been widely used as it is known to give punctate signals
that mark the inner kinetochore of the centromere re-
gion. Nonetheless, the binding of this antibody to
CENP-A is obliterated if cells are fixed in methanol-
acetic acid solution [16]. On the other hand, a rabbit
polyclonal serum generated against full-length human
CENP-C by the Earnshaw laboratory was shown to work
on methanol-acetic acid fixed cells as reported by
Warburton et al. [9]. In addition, CENP-C perfectly co-
localises with CENP-A and both are constitutive markers
of active centromeres [17] but the supply of the rabbit
serum against CENP-C is limited.
Results and discussion
Centromere antibody screening
With the awareness that most samples in the cytogenetic
laboratories are stored long-term in methanol-acetic acid
fixative and with the expectation that centromere status
screening will provide useful information for these la-
boratories, we decided to screen several commercially
available antibodies that target components of an active
centromere using fixed HCT-15, a near diploid and
lowly rearranged human colon cancer cell line [4].
From our screen, as summarised in Table 1, antibodies
that did not show centromere signals on methanol-
acetic acid fixed cells are the rabbit polyclonal antibody
recognizing phosphorylated Ser18 of CENP-A (Active
Motif ) and the rabbit monoclonal against BubR1
[EPR12259(2)] (Abcam), a spindle assembly checkpoint
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protein of the BUB1B gene that plays a role in sensing
proper chromosome-microtubule attachments during
prometaphase to metaphase when it localises to the
kinetochore (Fig. 1) [18]. The mouse monoclonal anti-
body against HEC1 (NDC80) [9G3] (Abcam), a protein
of the NDC80 complex that stabilises microtubule-
kinetochore binding, was also negative for centromere
signals on fixed cells. Rabbit monoclonal against CENP-
E [EPR4542(2)] (Abcam), a kinesin-like motor protein
that accumulates at the kinetochore throughout meta-
phase [19], gave positive signals at the centromere re-
gions but its staining was not homogeneous across all
human chromosomes (Fig. 1), making it not ideal for the
utilisation we were aiming for. Rabbit monoclonal
against CENP-C [EPR15939] (Abcam) probed on fixed
HCT-15 showed positive punctate signals (Fig. 1) similar
to the signals seen in immunocytochemistry on non-
fixed, cytocentrifuged cells even when it was used at a
high dilution factor of 1 in 3,000 (data not shown).
Combining cenFISH, CENP-IF and mFISH methods
After validating that the rabbit monoclonal against human
CENP-C worked on fixed cells, we then cross-linked the
primary and secondary antibodies before performing α-
satellite FISH (cenFISH). This combined method of centro-
mere protein immunofluorescence (CENP-IF) followed by
cenFISH will be referred to as CENP-IF-cenFISH here on-
wards. In addition to the epigenetics and DNA-based infor-
mation of the centromere activity, we believe that knowing
the identity of the chromosomes would further add value
to cytogenetic analysis. Hence, we attempted to carry out
mFISH on the same cell spread on which CENP-IF-
cenFISH had been performed prior and to ensure that
mFISH would work sufficiently well post-CENP-IF-
cenFISH, we compared the combination of methods as out-
lined in Fig. 2 using the HEL cell line (Fig. 3).
In general, the chromosome morphology of cytocentri-
fuged cells was not well-maintained compared to the meta-
phase spread of cells stored in methanol-acetic acid fixative
(unpublished observation). However, we were still able to
distinguish the chromosome identities with the mFISH pro-
cedure followed by image analysis (Fig. 3c) as seen in the
comparable karyotypes generated from all methods (Fig. 3).
In our experiments, the cross-linking step with formalde-
hyde for antibodies against CENP-A and CENP-C prior to
cenFISH in methods C and D respectively caused the red
fluorescent signals at the active centromere regions to carry
over into the mFISH analysis (Fig. 4b, lower panel). The
green fluorescent signals from cenFISH were not detectable.
Thus, by taking the carrying over of fluorescent antibody
signal into account, we suggest the preparation of an add-
itional sample but using a differently coloured secondary
antibody against anti-CENP-A or anti-CENP-C for more
accurate chromosome identification by mFISH post- CENP-
IF-cenFISH if necessary.
Comparison between CENP-IF-cenFISH-mFISH with
CENP-A and CENP-C
Referring to Fig. 2, method A is the standard mFISH per-
formed according to the protocol recommended by the
manufacturer (MetaSystems) and it is a useful method to
identify interchromosomal translocations but is unable to
identify rearrangements involving α-satellite DNA espe-
cially the ones without observable constrictions. However,
with method B, cenFISH followed by mFISH, multiple α-
satellite signals were observed on two large chromosomes
designated (i) and (ii) (Fig. 3b). Even in combination with
DAPI staining of the DNA where chromosome constric-
tions may be identified, identification of the centromere
was proven to be not trivial in HEL cell line especially on
the chromosome denoted (i). However, through methods
Table 1 List of antibodies targeting components of active centromere. Antibodies were first tested on non-fixative treated cells to deter-
mine optimal concentration or dilution for immunocytochemistry and then tested on cells stored in methanol-acetic acid fixative
Antibody Species Concentration or
dilution
Cells stored in methanol-acetic
acid
1 BubR1 [EPR12259(2)] ab183496 (Abcam) Rabbit IgG
monoclonal
0.527 μg/ml No
2 CENP-A (Clone: 3–19) Mouse IgG
monoclonal
1 : 500 No
3 CENP-A phospho Ser18 (Active Motif) Rabbit IgG polyclonal 1 : 400 No
4 CENP-C (Serum from rabbit 554; gift from William
Earnshaw)
Rabbit polyclonal 1 : 1000 Yes
5 CENP-C [EPR15939] ab193666 (Abcam) Rabbit IgG
monoclonal
0.677 μg/ml Yes
6 CENP-E [EPR4542(2)] ab133583 (Abcam) Rabbit IgG
monoclonal
0.275 μg/ml Not homogeneous across all
chromosomes
7 HEC1 [9G3] ab3613 (Abcam) Mouse IgG
monoclonal
0.5 μg/ml No
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C and D (both are CENP-IF-cenFISH-mFISH), the pres-
ence of CENP-A and CENP-C signals indicates which of
the two α-satellite positive constrictions was the active
centromere [Fig. 3c (i) and 3D (i)].
As reported in MacKinnon et al. [11], three derivative
chromosomes, namely der(4;20)t(4;11;20) and another
two that resulted from whole arm translocations between
two chromosomes, der(5;17) and der(10;19), contain
centromere sequences originated from two different chro-
mosomes. We were able to detect the presence of two
active centromeres based on CENP-C signals on at least
one der(10;19) chromosome in 2 out of 6 metaphase
spreads with method C [Fig. 3c (iii) and (iv)] and in 4 out
of 7 metaphase spreads using method D [Fig. 3d (iii)].
Der(5;17) and der(4;20) chromosomes were always show-
ing only a pair of punctate CENP-A and CENP-C signals.
Besides, the der(20)t(11;15;20) [Fig. 3d (iv)] in the meta-
phase spread of Fig. 3d was the only der(20) that showed
2 pairs of signals for CENP-C out of 7 metaphases
analysed. This raised the possibility of the centromere
of chromosome 15 being present on der(20) which
could not be tested by MacKinnon et al. [11].
Detection of neocentric and functional dicentric
chromosomes
To demonstrate the method’s utility, method D which used
anti-CENP-C was carried out on two cell lines, T-47D and
SN12C. T-47D is a breast cancer cell line known to us for
having a stable neocentric chromosome while SN12C is a
renal cancer cell line that shows a high proportion of
dicentric chromosomes in the metaphase spreads that we
analysed for another study (in preparation). In both in-
stances, our method was able to first detect centromere ab-
normalities within the metaphase spreads via CENP-IF-
cenFISH (Fig. 4a & b, upper panels), followed by identifica-
tion of the chromosomes that were involved in the final
rearranged and centromere defect-bearing chromosomes
(Fig. 4a & b, lower panels). The neocentromere in T-47D
Fig. 1 Active centromere antibody screening on methanol-acetic acid fixed cells. Representative images of immunocytochemistry using TEEN and
KB buffer performed on HCT-15 cells stored in methanol-acetic acid fixative. Immunofluorescence images showing BUBR1, CENP-E and CENP-C in
red and DAPI in cyan
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was found to be on a segment of chromosome 3 and
the neocentric chromosome was a product of re-
arrangement between chromosome 3 and 5 (Fig. 4a,
lower panel) whereas the dicentric chromosome in
SN12C was formed from the rearrangement between
chromosome 10 and 21 (Fig. 4b, lower panel).
In our study, we have demonstrated that our method,
CENP-IF-cenFISH-mFISH, was able to (1) identify
rearrangements implicating the centromeric DNA, (2)
identify active centromere based on the presence of the
constitutive kinetochore protein, CENP-C, and (3) reveal
the identity of the chromosomes involved in the rear-
rangements for methanol-acetic acid fixed cells.
We hereby propose that this method will be particularly
helpful in studying clinicopathologically complex groups
of tumours, for example liposarcomas, potentially as an
additional criterion in subcategorising them. Both atypical
lipoma/well-differentiated liposarcoma (ALP-WDLPS)
and dedifferentiated liposarcoma (DDLPS) are identified
by the presence of similar marker chromosomes, namely
the supernumerary ring or giant rod chromosome con-
taining the amplified 12q14-15 region with amplification
of the MDM2 and CDK4 genes. However, ALP-WDLPS is
classified as having intermediate aggressiveness compared
to DDLPS which is malignant [20]. In addition, a high
proportion of ALP-WDLPS has a marker chromosome
with a neocentromere in contrast to DDLPS that also has
the marker chromosome containing amplified 12q14-15
but with alphoid-centromere [21, 22].
Functionally dicentric chromosomes with two active
centromeres have been thought to be involved in the
breakage-fusion-bridge cycle and have recently been
suggested to also contribute to chromothripsis based on
the modelling of a subset of pa ediatric acute lympho-
blastic leukaemia (ALL) with intrachromosomal amplifi-
cation of chromosome 21 [23]. Furthermore, in refining
the treatment for patients of pa ediatric ALL, the pres-
ence or absence of a dicentric chromosome was consid-
ered alongside other cytogenetic and genomic criteria
[24], and in a recent acute myeloid leukaemia (AML)
study, the difference in median survival between patients
with one dicentric (5.8 months) and those with three
dicentric chromosomes (1.8 months) was shown to be
significant [25]. Taken together, our method which has
the capability to detect functional dicentric chromo-
somes in methanol-acetic acid fixed cytogenetic prepara-
tions could assist in understanding the involvement of
dicentric chromosomes in disease mechanism and also
in risk stratification of patients for the treatment of
diseases other than childhood ALL and AML.
Furthermore, this method could also be applied to pre-
natal and congenital cases with chromosomal rearrange-
ments containing centromere abnormalities that are not
detected with current genomic technologies such as
SNP microarrays and massively parallel sequencing [26].
An example of such chromosomal rearrangements is the
isodicentric Y [idic(Y)], commonly found in children
with disorders of sex development. Patients presented
Fig. 2 Workflow combining and comparing mFISH, cenFISH and CENP-IF. a Standard mFISH as suggested by MetaSystems. b cenFISH-mFISH:
pan-centromeric FISH with pTRA7 α-satellite probes, designated as cenFISH, imaged with metaphase spreads coordinates recorded and under-
went mFISH. c Freshly harvested cells swelled in hypotonic solution were cytospun onto microscope slide before immunofluorescence was per-
formed using KCM buffer, cross-linked with 4 % formaldehyde, fixed and denatured with methanol-acetic acid, aged, underwent cenFISH and
subsequently mFISH. d Immunofluorescence using TEEN and KB buffer was performed on cells stored in methanol-acetic acid fixative, cross-
linked with 4 % formaldehyde before cenFISH and then mFISH was performed. Both methods c and d are CENP-IF-cenFISH-mFISH




Fig. 3 (See legend on next page.)
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with idic(Y) are often mosaic with 45,X cells and a high
proportion of females presented with 45,X Turner syn-
drome have the X chromosome of maternal origin,
which together suggest that idic(Y) is mitotically un-
stable [27, 28]. In addition, idic(Y) is the most common
structural anomaly of chromosome Y in infertile men
exhibiting an abnormal Y chromosome [28]. An azoo-
spermic prospective father with idic(Y) may seek assisted
reproductive technologies (ART) to achieve parenthood
but he risks transmitting the idic(Y) to his offspring.
Hence, the detection of idic(Y) is important for pre- and
postnatal genetic counselling as well as for genetic
screening and recommendation of ART for infertile
men. However, for routine screening, anti-CENP-C
CENP-IF used together with chromosome specific FISH
probe would be a more economical approach.
Another important application of the method is in the
refinement of dicentric chromosome assay (DCA), the
gold standard for biodosimetry assessment of individuals
after exposure to radiation [29]. The International
Atomic Energy Agency recommends an analysis of more
than 1000 cells for better ascertainment of dicentric
a
b
Fig. 4 CENP-IF-cenFISH-mFISH performed on cancer cell lines T-47D and SN12C with neocentric and dicentric chromosome respectively. a Upper
panel: immunofluorescence images for T-47D showing α-satellite (green), CENP-C (red) and DAPI (blue); boxed in red is the neocentric chromosome
and insets are enlarged images of the neocentric chromosome. Lower panel: mFISH colour profile of the neocentric chromosome indicating
it is a rearranged chromosome containing segments from chromosomes 3 and 5. b Upper panel: immunofluorescence images for SN12C showing
α-satellite (green), CENP-C (red) and DAPI (blue); boxed in red is the dicentric chromosome and insets are enlarged images of the dicentric chromosome.
Lower panel: mFISH colour profile of the dicentric chromosome indicating it is a rearranged chromosome from chromosomes 21 and 10
(See figure on previous page.)
Fig. 3 Representative images of HEL metaphase for each method, with marked (i) der(9) and (ii) psu dic(22;9). a Standard mFISH. Metaphase
spread (left) and karyotype (right) in false colour. b cenFISH-mFISH. Upper panel: immunofluorescence images showing α-satellite (green) and
DAPI (blue); insets are enlarged images of (i) der(9) and (ii) psu dic(22;9). Lower panel: metaphase spread and karyotype in false colour. c CENP-IF-
cenFISH-mFISH with CENP-A. Upper panel: immunofluorescence images of cytospun cells showing α-satellite (green), CENP-A (red) and DAPI (blue);
insets are enlarged images of (i) der(9) and (ii) psu dic(22;9). Lower panel: metaphase spread and karyotype in false colour display. (iii) and (iv) are
der(10;19) with two pairs of CENP-A signals. d CENP-IF-cenFISH-mFISH with CENP-C. Upper panel: immunofluorescence images showing α-satellite
(green), CENP-C (red) and DAPI (blue). Lower panel: metaphase spread and karyotype in false colour display; (i) and (ii) are der(9) and psu dic(22;9)
respectively while (iii) is der(10;19) and (iv) is der(20)t(11;15;20) (as named in MacKinnon et al. [11]) observed with two pairs of CENP-C signals
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chromosome formation for low radiation dose of less
than 100 mSv, equivalent to a computed tomography
(CT) scan [30, 31]. A recent study by Abe et al. [31] re-
ported that the analysis of 1000 metaphase spreads
probed with cenFISH was sufficient to yield comparable
precision to 2000 conventional Giemsa stained meta-
phases. However, these DCA methods only assess for
the occurrence of a dicentric chromosome based on the
presence of primary constrictions and centromere DNA,
therefore, not providing any information on whether the
affected chromosome contains one or two active centro-
meres which may have impacts on downstream genome
instability. This gap of information could be addressed
with the truncated version of our method D (excluding
the mFISH step) as a DCA. With an additional 2 h and
40 min approximately for immunocytochemistry on top
of cenFISH, it will provide the information on both the
centromere DNA and its associated active kinetochore
protein CENP-C, further improving the precision of the
current DCA methods.
Conclusions
The CENP-IF-cenFISH method using pan-centromeric
FISH probe and commercially available rabbit monoclo-
nal anti-CENP-C to detect active centromere performed
on methanol-acetic acid fixed cells is an improvement
on the existing DCA methods and prenatal and congeni-
tal testings for chromosome structure anomalies such as
isodicentric Y. Furthermore, the CENP-IF-cenFISH-
mFISH method which additionally reveals chromosome
identity could potentially add diagnostic value and in-
crease our understanding of disease mechanism if it was
to be incorporated into established procedures including
constitutional and cancer cytogenetic tests.
Methods
Cell culture
Cell lines namely HEL, HCT-15, T-47D and SN12C were
cultured in Roswell Park Memorial Institute (RPMI)
1640 with 10 % fetal bovine serum, 2 mM L-glutamine,
penicillin and streptomycin with 5 % CO2 at 37 °C [32].
Cell preparation & immunocytochemistry
For immunocytochemistry performed on freshly har-
vested cells, colcemid (KaryoMAX, Thermo Fisher
Scientific) was first added to cell medium to a final con-
centration of 0.1 μg/ml for 1.5 h. Cells were harvested
via mitotic shake-off and subjected to hypotonic treat-
ment (0.075 M KCl) for 15 min. 1500 cells were used for
each slide preparation. Cells cytospun onto the glass
slides were washed thrice with cold KCM (120 mM KCl,
20 mM NaCl, 10 mM Tris–HCl pH 7.5, 0.5 mM EDTA,
0.1 % Triton X-100) for 5 min each time and first incu-
bated with mouse anti-human CENP-A (1:500) then
followed by Alexa594 conjugated secondary antibody
against mouse (1:1000) (Thermo Fisher Scientific), both
diluted in KCM buffer with 1 % BSA, at 37 °C for 1 h
and 40 min respectively, with three 5 min KCM buffer
washes after each incubation. Cells were then cross-
linked in KCM containing 4 % v/v formaldehyde (Merck
Millipore) for 10 min at room temperature (RT), washed
twice with distilled water, briefly once and 5 min for an-
other, and air-dried before being fixed in ice-cold
methanol-acetic acid (methanol:acetic acid, 3:1 volume
ratio) at 4 °C for 30 min, air-dried and left to age for at
least 48 h at RT. Antibody screening was performed on
HCT-15 cells with the primary antibodies diluted ac-
cording to Table 1 followed by Alexa594 conjugated
secondary antibodies (1:1000) (Thermo Fisher Scientific)
against the respective species. The cells were visualised
without being fixed with methanol-acetic acid.
For immunocytochemistry on methanol-acetic acid
fixed cells, cells were dropped onto glass slides and
dipped immediately into TEEN buffer (1 mM
triethanolamine-HCl pH 8.5, 0.2 mM Na EDTA, 25 mM
NaCl) once the fixative had dried. TEEN buffer was
changed twice, after 3 min. Cells were blocked with
0.1 % Triton X-100 (Sigma-Aldrich) and 0.1 % BSA
(Sigma-Aldrich) in TEEN at 37 °C for 15 min followed
by incubation in rabbit anti-human CENP-C (1:3000)
(Abcam) in TEEN at 37 °C for 1 h. Slides were washed
with KB buffer (10 mM Tris–HCl pH 7.7, 150 mM
NaCl, 0.1 % BSA) thrice, 4 min each time before incu-
bating with Alexa594 conjugated secondary antibody
against rabbit (1:1000) (Thermo Fisher Scientific) diluted
in KB buffer at 37 °C for 40 min. Slides were then
washed twice with KB for 4 min each time before being
fixed in KB containing 4 % formaldehyde for 10 min at
RT, washed twice with water, briefly once and 5 min for
another, and then air-dried. For antibody screening, after
the washing step post-secondary antibody incubation,
slides were mounted with Vectashield antifade mounting
medium (Vector Laboratories) added with DAPI before
visualisation.
Pan-centromeric probes
The pTRA-7 plasmid containing pan α-satellite DNA
(previously described in [33]) was labelled with biotin
using the dCTP analog conjugated with biotin (Thermo
Fisher Scientific). 2 μg plasmid DNA, 0.2 mM dNTP
mix (Promega), NEBuffer 2 (New England BioLabs Inc.),
0.1 mg/ml BSA, 160 mU DNaseI (New England BioLabs
Inc.) and 20 U DNA Polymerase I (New England Bio-
Labs Inc.) were mixed into a final reaction volume of
30 μl and incubated at 15 °C for 2.5 h for nick transla-
tion. The reaction was then inactivated at 75 °C for
20 min. DNA was precipitated overnight at −20 °C with
20 μg of salmon sperm DNA (Thermo Fisher Scientific),
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0.1 volumes NaOAc and 2.5 volumes of 100 % ethanol.
Precipitated DNA was spun down, washed with 70 %
ethanol and subsequently air-dried. The DNA pellet was
then resuspended in 40 μl hybridisation buffer (30 %
formamide, 2 X SSC, 10 % dextran sulfate) before being
denatured at 95 °C for 5 min and then placed on ice.
This was a modification based on Roche’s Nick Transla-
tion Kit protocol.
FISH
For cells that were to be probed directly, colcemid was
added to the cell medium to a final concentration of
0.1 μg/ml for 1.5 h. Cells were trypsinised, spun down
for 4 min and washed once with phosphate-buffered sa-
line (PBS) before being subjected to hypotonic treatment
in 0.075 M KCl at 37 °C for 15 min. Cells were then
fixed by adding ice-cold methanol-acetic acid, spun
down, resuspended with the fixative after discarding the
supernatant and this process was repeated once and the
pellet was resuspended in a final 200–800 μl of fixative
to yield an optimal cell density for metaphase spread
preparation. Fixed cells were dropped onto glass slides
and aged for at least 48 h at RT before performing FISH.
Biotinylated probes against α-satellites were co-
denatured with DNA on the slides at 71 °C for 5 min
and incubated in a humidified chamber at RT for 16–
18 h. Slides were then (i) washed using 2 X saline-
sodium citrate (SSC) buffer twice followed by 1 X SSC
buffer thrice, each time at RT for 5 min, (ii) blocked with
Tris-NaCl-Blocking (TNB) [0.1 M Tris-HCl pH 7.5,
150 mM NaCl, 0.5 % w/v Blocking Reagent (Roche)]
buffer at 37 °C for 30 min, (iii) incubated with avidin
conjugated with Alexa-488 (dilution 1:500) (Thermo
Fisher Scientific), (iv) washed thrice with 4 X SSC with
0.05 % v/v Tween-20 at 37 °C for 5 min each time and
(v) mounted with Vectashield antifade mounting
medium containing DAPI.
For cells that had undergone immunocytochemistry
with CENP-A, aged slides were co-denatured with α-
satellites probes at 75 °C instead of 71 °C for 5 min and
incubated in a humidified chamber at RT for 16–18 h.
Subsequent steps were the same as aforementioned.
mFISH
mFISH was carried out with 24 XCyte (MetaSystems)
according to the manufacturer’s instructions and with
omission of a few early steps for slides that had under-
gone FISH and Imm-FISH. Slides that had undergone
FISH only and immunocytochemistry followed by FISH
were washed in 1 X PBS at RT for 3 min and 2 X SSC at
70 °C for 30 min, allowed to cool to RT for about
20 min, washed in 0.1 x SSC at RT for 1 min, denatured
in 0.07 M NaOH at RT for 1 min, washed in 0.1 X SSC
followed by 2 X SSC at 4 °C for 1 min each wash and
then sequentially dehydrated in 30, 50, 70 and 100 %
ethanol at RT for 1 min each before being air dried.
Denatured 24 XCyte mFISH probes were then put onto
the slides and incubated in a humidified chamber at 37 °C
for 2 days. Post-hybridisation slides were washed in 0.4 X
SSC at 72 °C for 2 min, 2 X SSCT (2 X SSC containing
0.05 % v/v Tween-20) at RT for 0.5 min and rinsed briefly
in water before being air dried and mounted with Vecta-
shield antifade mounting medium containing DAPI for
visualisation.
Microscopy and analysis
All images were taken using a Zeiss Axio Imager.M1
microscope/AxioCam Mrm camera. All Imm-FISH im-
ages were captured and analyzed with Axio Vs40
vs4.6.1.0 software (Carl Zeiss) while mFISH images were
taken and analyzed with Isis colour fluorescence and
FISH imaging system (MetaSystems).
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